Low PSA radiographic disease progression on C11-choline PET.

Ahmed M MahmoudMohamed E AhmedA Tuba KendiMatthew ThorpeGeoffrey B JohnsonIrbaz Bin RiazJacob J OrmeEugene D KwonJack R AndrewsDaniel S Childs

Published in: BJUI compass (2023)

Men with prostate cancer commonly experience metastatic progression at very low or even undetectable PSA levels. Periodic imaging, even at low absolute PSA values, may result in more timely identification of disease progression.

Keyphrases

prostate cancer
radical prostatectomy
squamous cell carcinoma
high resolution
small cell lung cancer
computed tomography
pet imaging
bioinformatics analysis
photodynamic therapy